Triple
T20300973
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | AstraZeneca plc |
E505477
|
entity |
| Predicate | focusesOnTherapeuticArea |
P137286
|
FINISHED |
| Object | oncology |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: oncology | Statement: [AstraZeneca plc, focusesOnTherapeuticArea, oncology]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: focusesOnTherapeuticArea Context triple: [AstraZeneca plc, focusesOnTherapeuticArea, oncology]
-
A.
coreTherapeuticArea
chosen
Indicates the primary medical or clinical domain in which a therapy, treatment, or product is principally intended to be used.
-
B.
focusesOnMedicalCare
Indicates that one entity directs attention, resources, or activity specifically toward providing or improving medical care for another entity.
-
C.
notableBiosimilarArea
Indicates that an entity is significantly involved in, or recognized for, work related to a particular biosimilar product or therapeutic area.
-
D.
disciplinaryFocus
Indicates the primary academic or professional field, subject area, or discipline that something is centered on or concerned with.
-
E.
branchOfServiceFocus
Indicates that one entity is the primary military or organizational branch of service emphasized, specialized in, or targeted by another entity or activity.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4b8ab648190906e18538c250148 |
completed | April 16, 2026, 10:06 a.m. |
| NER | Named-entity recognition | batch_69e6770c700c81909da247cef0d0f1eb |
completed | April 20, 2026, 6:57 p.m. |
| PD | Predicate disambiguation | batch_69e55b21b09081909e46691b6f45a07f |
completed | April 19, 2026, 10:45 p.m. |
Created at: April 16, 2026, 11:16 a.m.